Synthesis and preliminary evaluation of a series of 18 2-phenyl-2H-pyrano [2,3- ). These studies also showed mean peak plasma levels of 17.0 and 4.2 ,ug of parent compound per ml after mice were given a single oral dose of 200 mg of MDL 20,610 or MDL 20,646 per kg, respectively. The current studies evaluated the in vitro activity of these 6-substituted analogs against a larger number of RVs and their effects on HeLa cells. Based on these data, one compound, MDL 20,610, was further evaluated for its activity against selected enteroviruses and nonpicornaviruses.
To assess in vitro antiviral efficacy, 2.0 mg of each compound was mixed with 0.02 ml of dimethyl sulfoxide followed by the addition of 10 ml of test medium to give a stock concentration of 200 ,ug of compound per ml. RV plaque assays were performed in quadruplicate on HeLa cells in 6-well microtiter plates (9) by 50% or more was considered the ICI,2.
In the yield reduction studies, HeLa cell monolayers in 6-well microtiter plates each received 2.0 ml of Eagle minimal essential medium supplemented with 1% heatinactivated fetal bovine serum and 1% PSN and containing 0 (virus control) or 0.0015 to 2.0 p.g of test compound per ml. After 3 h of incubation at 36 to 37°C each culture received 0.2 ml of virus suspension containing 2 x 102 to 3 x 104 PFU (multiplicity of infection of 0.0001 to 0.03). All variables were tested in triplicate. The cell cultures were incubated at 33°C for 72 to 96 h (until the virus control exhibited 50 to 75% cell destruction), and the titers of the pooled cell-supernatant harvests were determined by plaque assay (9) after three freeze (-50°C)-thaw cycles.
The effect of the compounds on the development of isolated HeLa cell colonies was determined as previously described (9) . The cytotoxic endpoint was considered to be the concentration of the compound which reduced the colony number by 50% or more. After this initial evaluation, the crystal violet was extracted from the stained colonies by the technique described by Schellekens and Stitz (6) . The A590 of the fluids harvested from each well was then determined with a spectrophotometer (model 25; Beckman Instruments, Inc., Fullerton, Calif.). Preliminary regression analysis (data not shown) showed that the optical density was linear (correlation coefficient of >0.99) at cell concentrations of 100 to 300,000 per microtiter plate well. The concentration of compound required to reduce the A590 by 50% when compared to the compound-free controls was considered the cell growth inhibitory concentration.
The effects of the compounds on host cell DNA, RNA, and protein synthesis were determined by techniques described previously (3, 9) . Briefly, cellular DNA synthesis was measured indirectly by the incorporation of [6-3H] thymidine into a trichloroacetic acid-insoluble cell fraction. Cellular RNA and protein synthesis were measured indirectly by the incorporation of [5-3H] uridine and a labeled L-amino acid mixture, respectively, into a trichloroacetic acid-insoluble cell fraction.
The plaque reduction data (Table 1) show that the 6-halogen analogs MDL 20,646 (6-Br) and MDL 20,957 were approximately fivefold more active by weight against RVs than was the 6-methylsulfonyl analog MDL 20,610. This difference was mirrored in the reduced production of infectious RV virions by compound-pretreated HeLa cells (Table  2) . HeLa cell growth studies, however, showed that MDL 20,957 was cytotoxic at concentrations as low as 10 jig/ml. In contrast, MDL 20,610 and MDL 20,646 were found to be noncytotoxic at concentrations up to 20 jig/ml. The 6- halogen analogs MDL 20,646 and MDL 20,957 also inhibited the growth of HeLa cell colonies at concentrations of 12.6 and 11.0 jig/ml, respectively, whereas MDL 20,610 only showed some inhibition at a test concentration of 20 ig/ml. These findings were confirmed in studies of the effects of the compounds on HeLa cell macromolecular synthesis (Fig. 2) . The overall spectrum of MDL 20,610 antiviral activity is shared with the 4',6-dichloroflavan BW683C (1), suggesting a common mechanism of action. Recent studies (7) showed that BW683C binds directly to infecting virions, inhibiting subsequent uncoating. This is a property shared with the arylalkyldiketone arildone (5) -(6-METHYLSULFONYL) (6-BROMO) 
